biotech · Lupus Nephritis · Primary or Secondary Progressive Multiple Sclerosis · KYTX
Kyverna Therapeutics
News and analysis for Kyverna Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
5980 Horton St, Suite 550, Emeryville, California 94608, US HQ
2018 Founded
155 Employees
Public company Type
KYTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 5980 Horton St, Suite 550, Emeryville, California 94608, US
- Founded
- 2018
- Employees
- 155
- Programs
- 14
- Drugs
- 31
- Patents
- 2
News & analysis
NovaPharmaNews articles mentioning Kyverna Therapeutics — regulatory, clinical, and market coverage.
News and analysis for Kyverna Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.